Creating A Compliant And Scalable CGT Logistics Launch Plan

The commercial delivery of cell and gene therapies (CGTs) presents unavoidable operational challenges. The entire supply chain must adhere to stringent requirements, including maintaining cryogenic temperatures, meeting delivery windows as short as 48 hours, and ensuring precise chain of identity tracking. Failure to manage these variables can compromise the therapy, leading to product loss and significant patient impact. Key logistical considerations include overcoming shipper capacity limitations, validating packaging choices, managing secondary packaging needs, and ensuring the compliant disposal of biohazardous materials. Developing a detailed, product-specific logistics strategy before commercialization is critical to mitigating these risks and ensuring the therapy reaches patients safely and on time.

Discover crucial recommendations to help you anticipate and overcome the logistical hurdles of CGT delivery.